Sign In

Christopher Wegener

Director, Cell Therapy R&D

Christopher Wegener is the Director of Cell Therapy Research and Development (R&D) at Fresenius Kabi USA. He has a strong background in biomedical engineering, holding a Master's Degree from the University of Wisconsin. Wegener has been instrumental in the development of advanced technologies for cell and gene therapy, particularly focusing on CAR-T cell therapy.14

In his role, Wegener oversees the development of innovative cell processing systems, such as the Lovo and Cue systems, which are designed to enhance the efficiency and flexibility of CAR-T cell production. These systems are notable for their automation capabilities and are specifically engineered to support various workflows in cell therapy manufacturing.13 Under his leadership, Fresenius Kabi has made significant strides in adapting existing technologies from transfusion medicine to meet the growing needs of the cell and gene therapy sector.12

Wegener's work is pivotal as the industry seeks to streamline production processes and reduce costs associated with CAR-T therapies, ultimately aiming to make these treatments more accessible to patients.3 His contributions have positioned Fresenius Kabi as a key player in the rapidly evolving field of cell and gene therapy.

Highlights

Oct 10 · linkedin

Great news! We are very excited for Cue to help bring safe, reliable, and accessible cell-based medicines to more people around the world!

Sep 23 · linkedin

Join Fresenius Kabi on Thursday, September 29 for a RegMedNet panel discussion on cryopreservation. Sign up to hear perspectives from industry experts and gain insight into the world of cryopreservation in the cell and gene therapy space. Register today: https://bit.ly/3xIalqX #caringforlife #cryopreservation #celltherapy #celltherapymanufacturing

Related Questions

What inspired Chris Wegener to transition into cell therapy R&D?
How did Fresenius Kabi's experience in transfusion medicine benefit their entry into cell therapy?
What are the key differences between the Lovo and Cue cell processing systems?
How does Chris Wegener see the future of cell therapy evolving in the next decade?
What challenges did Chris Wegener and his team face when developing the Lovo and Cue systems?
Christopher Wegener
Christopher Wegener, photo 1
Christopher Wegener, photo 2
Add to my network

Location

Libertyville, Illinois, United States